Related Experiment Video
Updated: Jun 17, 2026
09:35
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
Published on: July 16, 2016
Beta-cell development and turnover during prenatal life in humans
Juris J Meier1, Christina U Köhler, Bacel Alkhatib
1Department of Medicine I, St Josef-Hospital, Ruhr-University of Bochum, Gudrunstrasse 56, Bochum 44791, Germany. juris.meier@rub.de
European Journal of Endocrinology
|December 22, 2009
Summary
Human prenatal pancreas development shows beta-cells appear by week 9. High beta-cell replication drives prenatal beta-cell mass expansion, crucial for understanding diabetes treatment.
Area of Science:
- Developmental biology
- Endocrinology
- Regenerative medicine
Background:
- Understanding human prenatal beta-cell development is crucial for diabetes research.
- Quantitative changes in fetal pancreatic beta-cell mass are not well understood.
Purpose of the Study:
- To determine the timing of beta-cell occurrence and islet growth in prenatal humans.
- To investigate the dynamics of beta-cell replication and apoptosis during human fetal development.
Main Methods:
- Analysis of 65 human embryonic and fetal pancreatic tissues (8 weeks post conception to birth).
- Immunohistochemical staining for insulin, glucagon, proliferation (Ki67), apoptosis (TUNEL), and blood vessels (CD31).
- Morphometric analysis to quantify beta-cell area, replication, and apoptosis.
Main Results:
- Beta-cells were detected from 9 weeks post conception; glucagon expression was observed at 8 weeks.
- Fractional beta-cell area increased linearly until birth; beta-cell replication was evident from 9 weeks.
- High rates of beta-cell apoptosis (1.5+/-0.3%) and a close relationship between islet and blood vessel development were observed.
Conclusions:
- Human beta-cell differentiation begins around 9 weeks post conception, originating near ductal epithelium.
- Significant beta-cell replication during prenatal development is a key mechanism for increasing beta-cell mass.
- These findings provide insights into early pancreatic development relevant to diabetes research.
Related Concept Videos
01:23Tissue Renewal without Stem Cells
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
However, failure of such a system...
01:27Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are co-secreted in...
Insulin and C-peptide are co-secreted in...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:22Development of Immunocompetence
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
01:05Insulin Secretory Vesicles
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...